Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
arrangement, Authorisation, colorectal, EGFR, Haematology, Hellenic, IND, instruction, linvoseltamab, monoclonal, mutant, pancreatic, panitumumab
Removed:
aberrant, acceptable, adequate, affecting, appointed, authorization, billion, breach, broader, California, capitalize, chain, corporation, customer, decline, decreased, Department, deposit, deterioration, difficult, economy, event, exceed, fail, failed, guarantee, impaired, innovation, institution, international, involving, led, longer, macroeconomic, manner, mitigate, occurred, pandemic, requiring, reserve, resulting, secured, similarly, statement, strategy, supplier, thereunder, Treasury, turn, variety, wage, widespread
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view